Fresenius USA Manufacturing, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Phosphate Kinetic Modeling

Not Applicable

Completed

Conditions: Hyperphosphatemia
End Stage Renal Disease

Interventions: Other: Computer algorithm management of hyperphosphatemia

First Posted Date: 2009-10-28

Last Posted Date: 2014-08-18

Lead Sponsor: Fresenius Medical Care North America

Target Recruit Count: 190

Registration Number: NCT01003223

Locations: 🇺🇸
Fresenius Medical Services, Waltham, Massachusetts, United States

Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers

Phase 1

Completed

Conditions: Hyperphosphatemia

Interventions: Drug: Calcium Acetate 667 mg GelCaps
Drug: Calcium Acetate Oral Solution 667 mg per 5 mL
Dietary Supplement: Calcium Citrate 950 mg Caplets

First Posted Date: 2008-08-28

Last Posted Date: 2009-02-09

Lead Sponsor: Fresenius Medical Care North America

Target Recruit Count: 46

Registration Number: NCT00742820

Locations: 🇺🇸
Community Research, Cincinnati, Ohio, United States

Inflammation and Nutritional Parameters in Hemodialysis Patients Using Reprocessed Dialyzers

Completed

Conditions: End Stage Renal Disease
Inflammation

First Posted Date: 2007-02-27

Last Posted Date: 2008-05-07

Lead Sponsor: Fresenius Medical Care North America

Target Recruit Count: 2500

Registration Number: NCT00440908

Locations: 🇺🇸
Fresenius Medical Care North America, Waltham, Massachusetts, United States

ProStat Supplementation in Dialysis Patients

Not Applicable

Terminated

Conditions: Malnutrition
ESRD

Interventions: Dietary Supplement: Placebo supplement
Dietary Supplement: Nutritional Supplement ProStat 64 twice a day

First Posted Date: 2007-02-14

Last Posted Date: 2008-02-21

Lead Sponsor: Fresenius Medical Care North America

Target Recruit Count: 16

Registration Number: NCT00435123

Locations: 🇺🇸
Metro Hypertension & Kidney Center, LLC., St. Louis, Missouri, United States
🇺🇸
Kansas Nephrology Physicians, PA, Wichita, Kansas, United States
🇺🇸
Nephrology Associates, Columbus, Mississippi, United States

and more 3 locations

Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients

Phase 4

Completed

Conditions: Kidney Failure

Interventions: Drug: Paricalcitol

First Posted Date: 2006-02-22

Last Posted Date: 2010-04-08

Lead Sponsor: Fresenius Medical Care North America

Target Recruit Count: 64

Registration Number: NCT00294866

Locations: 🇺🇸
Nephrology Center, Kalamazoo, Michigan, United States
🇺🇸
Delaware Valley Nephrology, Philadelphia, Pennsylvania, United States
🇺🇸
Nephrology Associates, PC, Nashville, Tennessee, United States

and more 3 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy